A Vascular Health Estrogen Marker is a specific, measurable biological molecule or ratio that reflects the protective or detrimental influence of estrogen and its metabolites on the structure and function of the cardiovascular system. These markers, which can include specific estrogen metabolites or downstream signaling molecules, provide clinical insight into a woman’s cardiovascular risk profile, particularly during perimenopause and post-menopause. They are used to assess the efficacy of hormone-based interventions.
Origin
This term is derived from cardiovascular endocrinology, emphasizing the role of “estrogen” in maintaining “vascular health.” The recognition of sex-specific differences in heart disease and the protective role of endogenous estrogen led to the search for quantifiable biomarkers. The focus extends beyond total estrogen to the functional balance of its various metabolites.
Mechanism
Estrogen, primarily estradiol, exerts a vasodilatory effect by increasing the bioavailability of nitric oxide (NO) in the endothelial cells, thereby promoting vascular relaxation and reducing arterial stiffness. Specific estrogen metabolites, such as 2-hydroxyestrone, are considered more favorable than others, like 16-hydroxyestrone, in terms of their overall impact on inflammation and cell proliferation within the vascular wall. The marker thus reflects the net protective or pro-atherogenic signaling mediated by the estrogen pathway.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.